MAPK8 and cutaneous squamous cell carcinoma: In some cases, inhibition of JNK signaling is clearly counter-indicated; in cutaneous squamous cell carcinoma (cSCC), the inhibition of JNK protects cells from UV-induced cell death (Vin et al, 2013).